What is Proton Therapy
Read our Covid-19 policy

Call Now For More Information

General Questions or
Schedule an Appointment

1-855-528-7248

Current Patients

1-206-306-2800

Physician Line

1-888-987-7782

Read our Covid-19 policy

Dr. George Laramore Receives Lifetime Achievement Award

Dr. George Laramore Receives Lifetime Achievement Award

Dr. George Laramore, MD, PhD, FACR, FASTRO, has been named the 2019 recipient of the National Association for Proton Therapy Lifetime Achievement Award!

The award is presented every year to an individual who has made significant contributions to the field of proton therapy. Dr. Laramore has worked tirelessly to investigate, treat, and provide proton therapy access to patients in the Pacific Northwest and beyond..

Dr. Laramore was born in Ottawa, Illinois, and attended Purdue University, University of Illinois, and University of Miami. He subsequently pursued postgraduate training in Radiation Oncology at the University of Washington, where he was the architect of the clinical neutron program. Due to his efforts, the University remains the sole clinical neutron facility in North America today.

While on faculty at the University of Washington, Dr. Laramore led numerous clinical trials, both early phase and randomized trials to test the value of neutron therapy for patients. As an author or co-author of 14 clinical trials examining neutron therapy, Dr. Laramore is one of the foremost clinical trialists in particle beam therapy.

In 1997, Dr. Laramore was promoted to the position of Acting Chair of the Department of Radiation Oncology at the University of Washington and subsequently assumed the position of permanent Chair in 1999. In this capacity, Dr. Laramore was a tireless proponent of bringing proton beam therapy to the Pacific Northwest. The SCCA Proton Therapy Center opened for treatment in March 2013, due in large part to his advocacy. To date, the Center has treated nearly 3,000 patients.

“Dr. Laramore is truly one of the founding fathers of modern particle beam therapy in the United States,” said Dr. Ramesh Rengan, Professor and Interim Chair, Department of Radiation Oncology, University of Washington School of Medicine, and Medical Director of SCCA Proton Therapy Center. “He has dedicated his life not only to his patients, but to the global cause and advocacy of particle therapy. To put it simply – we owe him a huge debt of gratitude and I know that our proton center would not be here without him. It has been an honor to work alongside Dr. Laramore, and we congratulate him for this well-deserved honor.”

“Dr. Laramore is an accomplished medical professional, and a globally-recognized leader and champion of proton therapy,” says Annika Andrews, president and CEO of SCCA Proton Therapy Center. “Here in the Pacific Northwest, Dr. Laramore’s invaluable contributions to the field will be felt for many years to come. As a driving force behind the creation of our center, Dr. Laramore has given thousands of patients access to proton therapy. It is a privilege to honor him with his recognition.”

Dr. Laramore will be recognized later this month at the 2019 National Proton Conference in Miami, Florida. For more information on the NAPT, visit www.proton-therapy.org.